Drug Profile
AG 1284
Alternative Names: AG 1157; AG 1345Latest Information Update: 21 Jun 1995
Price :
$50
*
At a glance
- Originator Agouron Pharmaceuticals
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 01 May 1995 Discontinued-Preclinical for HIV-1 infections in USA (PO)